Public Profile

3sbio

3SBio Inc., a leading biopharmaceutical company headquartered in China, has established itself as a key player in the biotechnology industry since its founding in 1993. With a strong operational presence across major regions in Asia, 3SBio focuses on the development, manufacturing, and marketing of innovative therapies, particularly in the fields of oncology, nephrology, and autoimmune diseases. The company is renowned for its core products, including recombinant human erythropoietin and other biologics, which are distinguished by their high quality and efficacy. Over the years, 3SBio has achieved significant milestones, including successful product launches and strategic partnerships, solidifying its market position as a trusted provider of biopharmaceutical solutions. With a commitment to advancing healthcare, 3SBio continues to drive innovation and improve patient outcomes in the biopharmaceutical landscape.

DitchCarbon Score

How does 3sbio's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

24

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

3sbio's score of 24 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

72%

Let us know if this data was useful to you

3sbio's reported carbon emissions

In 2023, 3sbio reported total carbon emissions of approximately 60,649,530 kg CO2e, with Scope 1 emissions at about 11,663,450 kg CO2e and Scope 2 emissions at approximately 48,986,080 kg CO2e. This represents an increase from 2022, where total emissions were about 45,896,560 kg CO2e, with Scope 1 at approximately 7,257,230 kg CO2e and Scope 2 at around 38,639,330 kg CO2e. The company has not disclosed any specific reduction targets or initiatives as part of its climate commitments. However, it continues to monitor and report its emissions, focusing on transparency in its environmental impact. 3sbio's emissions data indicates a commitment to understanding and managing its carbon footprint, although no formal climate pledges or reduction targets have been established.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192020202120222023
Scope 1
5,960,680
0,000,000
0,000,000
0,000,000
00,000,000
Scope 2
42,724,590
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. 3sbio's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for 3sbio is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

3sbio is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Astra Zeneca

GB
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers